Wealth of Opportunity - The C1 Domain as a Target for Drug Development

E-ISSN： 1873-5592|9|8|641-652

ISSN： 1389-4501

Source： Current Drug Targets, Vol.9, Iss.8, 2008-08, pp. : 641-652

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Status and Future Prospects of C1 Domain Ligands as Drug Candidates

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 11, 2011-01 ,pp. : 1370-1392

Bentham Science Publishers

Access to resources Recommend Favorite

Claudin as a Target for Drug Development

Current Medicinal Chemistry, Vol. 18, Iss. 12, 2011-04 ,pp. : 1861-1865

Bentham Science Publishers

Access to resources Recommend Favorite

The NMDA/D1 Receptor Complex as a New Target in Drug Development

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-04 ,pp. : 801-808

Bentham Science Publishers

Access to resources Recommend Favorite

Toxicogenomics: an opportunity to optimise drug development and safety evaluation

By Kolaja Kyle L Kramer Jeffrey A

Expert Opinion on Drug Safety, Vol. 1, Iss. 3, 2002-09 ,pp. : 275-286

Informa Healthcare

Access to resources Recommend Favorite

The Prevention of Preterm Labour - Corticotropin Releasing Hormone Type 1 Receptors as a Target for Drug Design and Development

Mini Reviews in Medicinal Chemistry, Vol. 3, Iss. 4, 2003-06 ,pp. : 295-303

Bentham Science Publishers

Access to resources Recommend Favorite